Intractable epilepsy: management and therapeutic alternatives

Stephan U Schuele*, Hans O. Lüders

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

195 Scopus citations

Abstract

More than half of patients with newly diagnosed epilepsy achieve complete seizure control without major side-effects. Patients who continue to have seizures after initial medical therapy should have an early and detailed assessment to confirm the diagnosis, to determine the underlying cause and epilepsy syndrome, and to choose an adequate treatment strategy. The risks and potential benefits of surgical procedures or experimental therapy have to be weighed against the chance of improvement and the potential side-effects of additional medical therapy. Surgery for temporal lobe epilepsy, the most common cause of focal epilepsy, can control seizures and improve quality of life in appropriately selected patients. However, around 20-30% of patients do not respond to medical or surgical treatment. The management of chronic intractable epilepsy requires comprehensive care to address the adverse events of medical treatment, quality of life issues, and comorbid disorders. Much research focuses on the experimental treatment options that offer hope of seizure reduction or cure.

Original languageEnglish (US)
Pages (from-to)514-524
Number of pages11
JournalThe Lancet Neurology
Volume7
Issue number6
DOIs
StatePublished - Jun 1 2008

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Intractable epilepsy: management and therapeutic alternatives'. Together they form a unique fingerprint.

Cite this